Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
According to Vivani Medical, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00. At the end of 2022 the company had a P/S ratio of 0.00.
Year | P/S ratio |
---|---|
2023 | 0.00 |
2022 | 0.00 |
2021 | 0.00 |
2020 | 0.00 |
2019 | 25.84 |
2018 | 8.52 |
2017 | 12.99 |
2016 | 19.55 |
2015 | 23.45 |
2014 | 247.35 |
2013 | 1444.75 |
2012 | 1653.67 |